ERBB2 and cancer: In various cancer models, NDGA has been demonstrated to promote apoptosis and inhibit proliferation by suppressing the activities of lipoxygenase (LOX), insulin-like growth factor 1 receptor (IGF-1R) and human epidermal growth factor receptor 2 (HER2/neu) [5–8].